Accuray Incorporated logo

Accuray Incorporated (ARAY)

Market Open
3 Mar, 18:50
NASDAQ (NGS) NASDAQ (NGS)
$
0. 51
-0.04
-7.85%
$
68.6M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
$ 0.55
Previous Close
Day Range
0.49 0.55
Year Range
0.49 2.1
Want to track ARAY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ARAY earnings report is expected in 56 days (28 Apr 2026)
Accuray Incorporated (ARAY) Q3 2025 Earnings Call Transcript

Accuray Incorporated (ARAY) Q3 2025 Earnings Call Transcript

Accuray Incorporated (NASDAQ:ARAY ) Q3 2025 Earnings Call April 30, 2025 4:30 PM ET Company Participants Jesse Chew - Chief Legal Officer Suzanne Winter - President and Chief Executive Officer Ali Pervaiz - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Marie Thibault - BTIG Jason Wittes - ROTH Capital Operator Good day and welcome to the Accuray Third Quarter Fiscal 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.

Seekingalpha | 10 months ago
Accuray (ARAY) Reports Q3 Loss, Tops Revenue Estimates

Accuray (ARAY) Reports Q3 Loss, Tops Revenue Estimates

Accuray (ARAY) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.06 per share a year ago.

Zacks | 10 months ago
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now

Here's Why You Should Hold Accuray Stock in Your Portfolio for Now

ARAY continues to witness strength in its flagship CyberKnife system, along with robust global performance.

Zacks | 11 months ago
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now

Here's Why You Should Hold Accuray Stock in Your Portfolio for Now

ARAY continues to witness strength in its flagship CyberKnife system, along with robust global performance.

Zacks | 0 year ago
ARAY Stock Up as Q2 Earnings & Revenues Beat Estimates, Margins Up

ARAY Stock Up as Q2 Earnings & Revenues Beat Estimates, Margins Up

Accuray delivers solid fiscal second-quarter results, witnessing growth in Product revenues and reduced operating expenses.

Zacks | 1 year ago
Accuray Incorporated (ARAY) Q2 2025 Earnings Call Transcript

Accuray Incorporated (ARAY) Q2 2025 Earnings Call Transcript

Accuray Incorporated (NASDAQ:ARAY ) Q2 2025 Results Conference Call February 5, 2025 4:30 PM ET Company Participants Jesse Chew - Chief Legal Officer Suzanne Winter - President and Chief Executive Officer Ali Pervaiz - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Brooks O'Neil - Lake Street Capital Markets Operator Good day, and welcome to the Accuray Fiscal 2025 Second Quarter Financial Results Conference Call. All participants will be in a listen-only mode.

Seekingalpha | 1 year ago
Accuray (ARAY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Accuray (ARAY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Accuray (ARAY) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 1 year ago
Accuray (ARAY) Q2 Earnings and Revenues Top Estimates

Accuray (ARAY) Q2 Earnings and Revenues Top Estimates

Accuray (ARAY) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.10 per share a year ago.

Zacks | 1 year ago
Accuray (ARAY) Shows Fast-paced Momentum But Is Still a Bargain Stock

Accuray (ARAY) Shows Fast-paced Momentum But Is Still a Bargain Stock

Accuray (ARAY) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks | 1 year ago
ARAY Stock Gains as China Approves Latest Radiation Therapy Solutions

ARAY Stock Gains as China Approves Latest Radiation Therapy Solutions

Accuray announces the approval of the Chinese NMPA for its latest radiation therapy solutions.

Zacks | 1 year ago
Here's Why You Should Add Accuray Stock to Your Portfolio Now

Here's Why You Should Add Accuray Stock to Your Portfolio Now

ARAY's solid product demand and revenue growth raise optimism about the stock.

Zacks | 1 year ago
Here Is Why Bargain Hunters Would Love Fast-paced Mover Accuray (ARAY)

Here Is Why Bargain Hunters Would Love Fast-paced Mover Accuray (ARAY)

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Accuray (ARAY) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks | 1 year ago
Loading...
Load More